chr22-46793782-C-G
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_014346.5(TBC1D22A):c.401C>G(p.Pro134Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000225 in 1,601,234 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P134T) has been classified as Uncertain significance.
Frequency
Consequence
NM_014346.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152118Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000968 AC: 21AN: 216976 AF XY: 0.0000754 show subpopulations
GnomAD4 exome AF: 0.0000228 AC: 33AN: 1448998Hom.: 0 Cov.: 32 AF XY: 0.0000250 AC XY: 18AN XY: 720046 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152236Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74448 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.401C>G (p.P134R) alteration is located in exon 3 (coding exon 3) of the TBC1D22A gene. This alteration results from a C to G substitution at nucleotide position 401, causing the proline (P) at amino acid position 134 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at